SPDR S&P Pharmaceuticals ETF Rating $63.64 -0.14 (-0.22%) Closing price 10/2/2026 04:10 PM EasternExtended Trading$63.74 +0.10 (+0.16%) As of 10/2/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.62Holdings in XPH have an aggregate rating of Moderate Buy based on 348 analyst ratings issued in the past year covering 25 companies (48.5% of the portfolio).XPH Aggregate Price Target$63.64High Prediction$63.64Average Prediction$63.64Low Prediction$63.64Holdings in XPH have an aggregate price target of $63.64 and a range of $63.64 to $63.64 covering 25 companies (48.5% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings2.21%AMRXAmneal Pharmaceuticals$20.30+1.1%Moderate Buy$21.00 3.4%102.7178 of 5 starsAnalyst Forecast2.16%XERSXeris Biopharma$9.08-1.8%Hold$12.80 41.0%73.6134 of 5 starsNews CoverageInsider Trade2.14%MANEVeradermics$116.17-0.9%Moderate Buy$153.00 31.7%91.988 of 5 stars2.11%ANIPANI Pharmaceuticals$72.18-1.1%Hold$98.00 35.8%84.4462 of 5 starsInsider Trade1.96%DFTXDefinium Therapeutics$37.40-0.5%Buy$64.88 73.5%213.0969 of 5 starsInsider Trade1.96%LLYEli Lilly and Company$1,144.20-0.5%Moderate Buy$1,311.96 14.7%304.8609 of 5 starsTrending NewsAnalyst Forecast1.96%VTRSViatris$17.60+0.8%Moderate Buy$19.50 10.8%92.307 of 5 starsAnalyst Downgrade1.95%EWTXEdgewise Therapeutics$41.40+2.3%Moderate Buy$51.33 24.0%112.8572 of 5 stars1.93%INDVIndivior$35.71+0.9%Moderate Buy$45.17 26.5%73.512 of 5 stars1.93%SUPNSupernus Pharmaceuticals$42.38+0.5%Hold$62.83 48.3%73.5367 of 5 stars1.92%HRMYHarmony Biosciences$39.64+0.2%Hold$47.44 19.7%114.6982 of 5 starsPositive NewsAnalyst Forecast1.92%MRKMerck & Co., Inc.$144.24+0.3%Moderate Buy$145.76 1.1%273.5237 of 5 starsAnalyst Forecast1.91%LGNDLigand Pharmaceuticals$302.96+0.1%Buy$337.89 11.5%103.4638 of 5 stars1.91%JNJJohnson & Johnson$255.94-1.1%Moderate Buy$275.87 7.8%254.7485 of 5 starsTrending NewsAnalyst Forecast1.89%INVAInnoviva$20.50-0.2%Moderate Buy$39.25 91.5%63.2557 of 5 starsPositive News1.89%JAZZJazz Pharmaceuticals$235.67+1.1%Buy$291.15 23.5%204.2125 of 5 starsAnalyst Forecast1.89%AMLXAmylyx Pharmaceuticals$27.79-1.0%Buy$38.86 39.8%103.3978 of 5 starsNews Coverage1.89%OGNOrganon & Co.$13.74+0.2%Reduce$11.40 -17.0%71.5228 of 5 stars1.89%PFEPfizer$27.81-1.1%Hold$28.39 2.1%212.8789 of 5 starsTrending News1.87%PRGOPerrigo$14.28+1.9%Hold$19.33 35.4%63.3614 of 5 stars1.86%CORTCorcept Therapeutics$116.23+1.9%Moderate Buy$138.17 18.9%83.7348 of 5 stars1.85%AXSMAxsome Therapeutics$179.25-1.5%Moderate Buy$275.84 53.9%213.4504 of 5 starsNews CoverageAnalyst Forecast1.84%BMYBristol Myers Squibb$61.16-0.5%Moderate Buy$67.06 9.6%254.7491 of 5 starsAnalyst Revision1.84%ZTSZoetis$69.62+0.8%Hold$101.08 45.2%194.8408 of 5 stars1.83%MBXMBX Biosciences$58.51+3.5%Moderate Buy$83.89 43.4%132.8275 of 5 starsPositive NewsAnalyst Forecast This page (NYSEARCA:XPH) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
